Mangoceuticals Inc. recently completed share transactions with five accredited investors through four Subscription Agreements. On August 26 and August 29, 2025, the investors purchased a total of 709,677 shares of restricted common stock at a price of $1.55 per share, amounting to a total of $1,100,000. These transactions were conducted privately under exemptions from registration pursuant to Section 4(a)(2) and/or Rule 506 of Regulation D of the Securities Act of 1933.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mangoceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-012557), on September 02, 2025, and is solely responsible for the information contained therein.